JP2019519553A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019519553A5 JP2019519553A5 JP2018566519A JP2018566519A JP2019519553A5 JP 2019519553 A5 JP2019519553 A5 JP 2019519553A5 JP 2018566519 A JP2018566519 A JP 2018566519A JP 2018566519 A JP2018566519 A JP 2018566519A JP 2019519553 A5 JP2019519553 A5 JP 2019519553A5
- Authority
- JP
- Japan
- Prior art keywords
- pinf
- mutant
- variant
- seq
- pig
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022098147A JP7441892B2 (ja) | 2016-06-20 | 2022-06-17 | ペグ化ブタインターフェロンおよびその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662352163P | 2016-06-20 | 2016-06-20 | |
| US62/352,163 | 2016-06-20 | ||
| PCT/US2017/037964 WO2017222940A1 (en) | 2016-06-20 | 2017-06-16 | Pegylated porcine interferon and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022098147A Division JP7441892B2 (ja) | 2016-06-20 | 2022-06-17 | ペグ化ブタインターフェロンおよびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019519553A JP2019519553A (ja) | 2019-07-11 |
| JP2019519553A5 true JP2019519553A5 (https=) | 2020-01-30 |
| JP7093311B2 JP7093311B2 (ja) | 2022-06-29 |
Family
ID=59258379
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018566519A Active JP7093311B2 (ja) | 2016-06-20 | 2017-06-16 | ペグ化ブタインターフェロンおよびその使用方法 |
| JP2022098147A Active JP7441892B2 (ja) | 2016-06-20 | 2022-06-17 | ペグ化ブタインターフェロンおよびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022098147A Active JP7441892B2 (ja) | 2016-06-20 | 2022-06-17 | ペグ化ブタインターフェロンおよびその使用方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10960080B2 (https=) |
| EP (1) | EP3471755B1 (https=) |
| JP (2) | JP7093311B2 (https=) |
| KR (2) | KR102518451B1 (https=) |
| CN (2) | CN117024562A (https=) |
| AU (2) | AU2017280958A1 (https=) |
| BR (1) | BR112018076437A2 (https=) |
| CA (1) | CA3028683A1 (https=) |
| CL (1) | CL2018003697A1 (https=) |
| DK (1) | DK3471755T3 (https=) |
| EA (1) | EA036509B1 (https=) |
| ES (1) | ES2793773T3 (https=) |
| MX (1) | MX391970B (https=) |
| NZ (1) | NZ749962A (https=) |
| PL (1) | PL3471755T3 (https=) |
| PT (1) | PT3471755T (https=) |
| WO (1) | WO2017222940A1 (https=) |
| ZA (1) | ZA201808352B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3365340B1 (en) | 2015-10-19 | 2022-08-10 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| US20170145025A1 (en) | 2015-11-19 | 2017-05-25 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| ES2916874T3 (es) | 2015-12-17 | 2022-07-06 | Incyte Corp | Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1 |
| AU2016379372A1 (en) | 2015-12-22 | 2018-08-02 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| ES2906460T3 (es) | 2016-05-06 | 2022-04-18 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| ES2905980T3 (es) | 2016-05-26 | 2022-04-12 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| BR112018076534A2 (pt) | 2016-06-20 | 2019-04-02 | Incyte Corporation | compostos heterocíclicos como imunomoduladores |
| MA45669A (fr) | 2016-07-14 | 2019-05-22 | Incyte Corp | Composés hétérocycliques utilisés comme immunomodulateurs |
| ES2941716T3 (es) | 2016-08-29 | 2023-05-25 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| ES2874756T3 (es) | 2016-12-22 | 2021-11-05 | Incyte Corp | Derivados de triazolo[1,5-A]piridina como inmunomoduladores |
| AU2017382870B2 (en) | 2016-12-22 | 2022-03-24 | Incyte Corporation | Benzooxazole derivatives as immunomodulators |
| EP3558990B1 (en) | 2016-12-22 | 2022-08-10 | Incyte Corporation | Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers |
| WO2018119286A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Bicyclic heteroaromatic compounds as immunomodulators |
| ES2899402T3 (es) | 2016-12-22 | 2022-03-11 | Incyte Corp | Derivados de piridina como inmunomoduladores |
| CR20200520A (es) | 2018-03-30 | 2021-03-09 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| WO2019217821A1 (en) | 2018-05-11 | 2019-11-14 | Incyte Corporation | Tetrahydro-imidazo[4,5-c]pyridine derivatives as pd-l1 immunomodulators |
| EP4010342A1 (en) | 2019-08-09 | 2022-06-15 | Incyte Corporation | Salts of a pd-1/pd-l1 inhibitor |
| CN110343164A (zh) * | 2019-08-22 | 2019-10-18 | 安阳工学院 | 一种高活性7位点突变的猪干扰素α突变体及其制备方法和应用 |
| WO2021067217A1 (en) | 2019-09-30 | 2021-04-08 | Incyte Corporation | Pyrido[3,2-d]pyrimidine compounds as immunomodulators |
| BR112022009031A2 (pt) | 2019-11-11 | 2022-10-11 | Incyte Corp | Sais e formas cristalinas de um inibidor de pd-1/pd-l1 |
| US11780836B2 (en) | 2020-11-06 | 2023-10-10 | Incyte Corporation | Process of preparing a PD-1/PD-L1 inhibitor |
| WO2022099075A1 (en) | 2020-11-06 | 2022-05-12 | Incyte Corporation | Crystalline form of a pd-1/pd-l1 inhibitor |
| US11866434B2 (en) | 2020-11-06 | 2024-01-09 | Incyte Corporation | Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof |
| CN113845599B (zh) * | 2021-11-01 | 2023-09-19 | 长春萤火虫生物科技有限公司 | 一种重组猪干扰素融合蛋白及其应用 |
| WO2024241086A1 (en) | 2023-05-24 | 2024-11-28 | Ambrx, Inc. | Pegylated bovine interferon lambda and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858409B1 (en) * | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
| KR960705579A (ko) * | 1993-11-10 | 1996-11-08 | 에릭에스. 딕커 | 개선된 인터페론 중합체 결합체(Improved interferon polymer conjugates) |
| US5908621A (en) * | 1995-11-02 | 1999-06-01 | Schering Corporation | Polyethylene glycol modified interferon therapy |
| US20050226845A1 (en) * | 2004-03-10 | 2005-10-13 | Chih-Ping Liu | Method of treatment using interferon-tau |
| JP2006213597A (ja) * | 2000-07-19 | 2006-08-17 | Pepgen Corp | インターフェロン−タウを用いるｃ型肝炎ウイルスの処置のための組成物およびモニタリングの方法 |
| EP2327724A3 (en) | 2004-02-02 | 2011-07-27 | Ambrx, Inc. | Modified human growth hormone polypeptides and their uses |
| WO2006133089A2 (en) | 2005-06-03 | 2006-12-14 | Ambrx, Inc. | Improved human interferon molecules and their uses |
| US7695710B2 (en) * | 2005-06-20 | 2010-04-13 | Pepgen Corporation | Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs |
| CN101883784B (zh) | 2007-10-01 | 2014-10-15 | 药华医药股份有限公司 | N-端修饰的干扰素-α |
| PT2318029T (pt) | 2008-07-23 | 2018-01-10 | Ambrx Inc | Polipéptidos de g-csf bovino modificados e suas utilizações |
| CN104262480B (zh) * | 2014-09-28 | 2018-03-27 | 重庆理工大学 | 重组猪长效‑α干扰素的构建和修饰方法及其冻干注射剂的制备方法 |
-
2017
- 2017-06-16 KR KR1020227019809A patent/KR102518451B1/ko active Active
- 2017-06-16 CA CA3028683A patent/CA3028683A1/en active Pending
- 2017-06-16 PT PT177345840T patent/PT3471755T/pt unknown
- 2017-06-16 WO PCT/US2017/037964 patent/WO2017222940A1/en not_active Ceased
- 2017-06-16 JP JP2018566519A patent/JP7093311B2/ja active Active
- 2017-06-16 EA EA201892671A patent/EA036509B1/ru unknown
- 2017-06-16 NZ NZ749962A patent/NZ749962A/en unknown
- 2017-06-16 AU AU2017280958A patent/AU2017280958A1/en not_active Abandoned
- 2017-06-16 KR KR1020187036853A patent/KR102409470B1/ko active Active
- 2017-06-16 DK DK17734584.0T patent/DK3471755T3/da active
- 2017-06-16 CN CN202310995289.4A patent/CN117024562A/zh active Pending
- 2017-06-16 EP EP17734584.0A patent/EP3471755B1/en active Active
- 2017-06-16 PL PL17734584T patent/PL3471755T3/pl unknown
- 2017-06-16 ES ES17734584T patent/ES2793773T3/es active Active
- 2017-06-16 MX MX2018016295A patent/MX391970B/es unknown
- 2017-06-16 BR BR112018076437-0A patent/BR112018076437A2/pt active Search and Examination
- 2017-06-16 CN CN201780051072.0A patent/CN109641034B/zh active Active
- 2017-06-16 US US16/311,540 patent/US10960080B2/en active Active
-
2018
- 2018-12-11 ZA ZA2018/08352A patent/ZA201808352B/en unknown
- 2018-12-19 CL CL2018003697A patent/CL2018003697A1/es unknown
-
2021
- 2021-02-26 US US17/186,642 patent/US20210177980A1/en active Pending
- 2021-09-06 AU AU2021229132A patent/AU2021229132B2/en active Active
-
2022
- 2022-06-17 JP JP2022098147A patent/JP7441892B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019519553A5 (https=) | ||
| JP7441892B2 (ja) | ペグ化ブタインターフェロンおよびその使用方法 | |
| JP7719590B2 (ja) | Ｔｌｒアゴニストによる呼吸器感染症の治療 | |
| EA019965B1 (ru) | Комбинация ингибитора протеазы ns3 hcv с интерфероном и рибавирином | |
| WO2014139359A1 (zh) | 乙型肝炎疫苗 | |
| Liu et al. | Interferon as a mucosal adjuvant for an influenza vaccine in pigs | |
| JP2023517616A (ja) | 急性呼吸窮迫症候群およびウイルス感染の治療用のｃｘｃｒ４阻害剤 | |
| US8263562B2 (en) | Peptides for preventing or treating liver damage | |
| US20180338993A1 (en) | Treatment of hepatitis delta virus infection | |
| US11304989B2 (en) | Peptides for use in the treatment of viral infections | |
| EP1797112B1 (en) | Inhibitors of hepatitits c virus | |
| US9872895B2 (en) | TLR5 ligands, therapeutic methods, and compositions related thereto | |
| JP2020518588A5 (https=) | ||
| JP2014524450A5 (https=) | ||
| JP2009515933A (ja) | インフルエンザにおけるインターフェロン | |
| JP2007537280A (ja) | 免疫調節性化合物を用いる呼吸器のウイルス感染の治療又は予防 | |
| FANG et al. | Prokaryotic Expression and Anti‑PRRSV Activity Study of Porcine IFN‑α8 | |
| EA008766B1 (ru) | Интерферон-бета при тяжелом остром респираторном синдроме (sars) | |
| Sattoju et al. | Major Viral Outbreaks in the 1st Decade of 21st Century-Literature Review | |
| US20230277650A1 (en) | Use of a birnavirus for the treatment of a disease caused by varicella zoster virus (vzv) | |
| JPH02304100A (ja) | ブタの肺炎または関連細菌病の予防または治療に使用するためのインターフェロン | |
| Mohammed et al. | Therapeutic challenges of COVID-19: strategies of empirical treatment | |
| CN116685598A (zh) | 干扰素taufc-融合蛋白和治疗方法冠状病毒感染 | |
| HK1087358A (en) | Interferon beta in severe acute respiratory syndrome (sars) |